Citurgia Biochemicals appoints Kashi Nath Jha as CFO
Citurgia Biochemicals Limited has appointed Mr. Kashi Nath Jha as its Chief Financial Officer and Key Managerial Personnel effective May 29, 2026. The appointment was approved by the Board of Directors based on the recommendation of the Nomination and Remuneration Committee. Mr. Jha brings 28 years of experience in finance and accounts to the role.
*this image is generated using AI for illustrative purposes only.
Citurgia Biochemicals has appointed Mr. Kashi Nath Jha as its Chief Financial Officer and Key Managerial Personnel effective May 29, 2026. The appointment was approved by the Board of Directors during a meeting held on the same day, following a recommendation from the Nomination and Remuneration Committee. The decision was communicated to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Mr. Kashi Nath Jha brings extensive experience to the role, having spent 28 years in the field of Finance and Accounts. His expertise includes conducting feasibility studies, strategic financial planning, and the establishment of policies and mechanisms. He is also skilled in managing P&L operations and risk mitigation strategies.
The Board meeting, which commenced at 11:00 noon and concluded at 12:00 P.M. IST, formalized the appointment. The disclosure was made in compliance with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023.
Appointment Details
| Sr. No. | Details | Information |
|---|---|---|
| 1. | Reason for change | Appointment of Mr. Kashi Nath Jha as Chief Financial Officer & Key Managerial Person |
| 2. | Date of Appointment | May 29, 2026 |
| 3. | Brief profile | Mr. Kashi Nath Jha has extensive experience 28 years of in the field of Finance and Accounts. He is also an Expert in conducting feasibility studies, strategic financial planning, and establishment of policies and mechanisms, P&L operations, and risk mitigation. |
| 4. | Disclosure of relationships | Not Applicable |
Historical Stock Returns for Citurgia Biochemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.99% | -0.99% | +25.47% | +140.81% | +140.81% | +140.81% |
What strategic financial priorities will Mr. Jha likely focus on given his expertise in feasibility studies and planning?
How might this leadership change impact Citurgia Biochemicals' risk management framework in the coming years?
Could this appointment signal a shift in the company's capital allocation or expansion strategies?
18
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
